LPPR4 inhibitors refer to a class of chemical compounds specifically designed to interfere with the enzymatic activity and signaling function of Lysophospholipid Phosphatase-Related Protein 4 (LPPR4). LPPR4, a member of the LPP family of proteins, plays a crucial role in the regulation of lipid metabolism and cellular signaling. These inhibitors are characterized by their ability to target LPPR4 and modulate its functions, primarily within the context of cellular and molecular research.
Chemically, LPPR4 inhibitors encompass a diverse array of small molecules and compounds with various structures and properties. Many of these inhibitors function by binding to LPPR4's active site, where they compete with endogenous substrates such as lysophosphatidic acid (LPA) or other lipid molecules. By occupying this catalytic pocket, they disrupt LPPR4's phosphatase activity, preventing the dephosphorylation of specific lipid substrates. Consequently, this interference impacts downstream cellular signaling cascades, making LPPR4 inhibitors valuable tools for researchers studying these signaling pathways.LPPR4 inhibitors have proven instrumental in elucidating the intricate roles of LPPR4 in cellular processes such as lipid metabolism, cell proliferation, migration, and apoptosis. Researchers employ these compounds to manipulate LPPR4 function and observe the resulting effects on cellular behavior. The wide variety of LPPR4 inhibitors available in this class enables scientists to tailor their experiments to specific research questions, providing insights into the molecular mechanisms underlying LPPR4-mediated signaling pathways. This chemical class thus serves as an invaluable resource for advancing our understanding of the intricate biology associated with LPPR4 and related lipid signaling processes.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Ki16425 | 355025-24-0 | sc-221788 sc-221788A | 1 mg 5 mg | $199.00 $612.00 | 17 | |
Ki16425 is a selective LPPR4 inhibitor that competes with the substrate binding site of the enzyme. It blocks the conversion of lysophosphatidic acid (LPA) to phosphatidic acid (PA), disrupting the LPA signaling pathway, which is crucial for cell proliferation and migration. | ||||||
JTE 013 | 383150-41-2 | sc-203615 | 10 mg | $195.00 | 5 | |
JTE-013 is a LPPR4 inhibitor that competitively blocks the binding of lysophosphatidic acid (LPA) to LPPR4, thereby inhibiting LPA-induced signaling and cellular responses. | ||||||
Hydrogen Peroxide | 7722-84-1 | sc-203336 sc-203336A sc-203336B | 100 ml 500 ml 3.8 L | $31.00 $61.00 $95.00 | 28 | |
Hydrogen peroxide (H2O2) indirectly inhibits LPPR4 by increasing oxidative stress in cells, leading to the disruption of LPPR4's enzymatic activity. | ||||||
2-((3-(1,3-Dioxo-(1H)benzo[de]isoquinolin-2(3H)-yl)propyl)thio)benzoic Acid | 325850-81-5 | sc-497609 | 10 mg | $380.00 | ||
This compound, also called GRI977143, is a specific inhibitor of LPPR4 that interferes with its catalytic activity, blocking the dephosphorylation of lysophosphatidic acid (LPA). | ||||||
LCL-161 | 1005342-46-0 | sc-507541 | 10 mg | $360.00 | ||
LCL161 is a LPPR4 inhibitor that disrupts its interaction with downstream signaling molecules, thereby inhibiting LPA-induced cellular responses. | ||||||
E-64 | 66701-25-5 | sc-201276 sc-201276A sc-201276B | 5 mg 25 mg 250 mg | $281.00 $947.00 $1574.00 | 14 | |
E64 indirectly inhibits LPPR4 by interfering with cellular protease activity, which is necessary for LPPR4 maturation and activation. | ||||||